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ABSTRACT
Background: During pregnancy, Low serum 25-hydroxyvitamin-D [25(OH)D] concentration is even more critical. This deficiency 
leads to higher incidences of preeclampsia, gestational diabetes,preterm birth, bacterial vaginosis, and also affects the health 
of the infants. The aim of this study was to evaluate the relationships between serum levels of 25-hydroxyvitamin D (25[OH]D) 
and gestational diabetes mellitus (GDM) and differences in high-risk pregnant women and women without risk factors for GDM. 
Methods: This cross sectional study including 155 pregnant women, who are still in the first trimester of pregnancy (less than 
12 weeks gestation), were randomized to two groups of high and low risk for GDM. For these people, once at the gestational 
age less than 12 times a week and once at for 24 to 28 weeks of pregnancy, tests of FBS / BS / HbA1C / 25OHD / insulin / Ca / 
Albumin was requested. Besides, the OGTT test was performed with 75 g glucose at 24 and 28 weeks of pregnancy to diagnose 
GDM. Results: Serum levels of 25(OH)D in the second trimester of pregnancy ng / ml (24.1 ± 39.5) was significantly lower than 
that of the first trimester ng / ml (25.9 ± 45.6) (p <0.001).But serum 25(OH)D levels in the first and second trimester of preg-
nancy was significantly different in women at high risk for GDM than women who had no risk factors (p =0.584 and p =0.99). 
Serum levels of 25(OH)D has an inverse and significant relationship with HbA1C at the beginning of pregnancy (p=0.007). In 
addition, a significant and inverse relationship was shown between serum levels of 25(OH)D in the second trimester with insulin 
(p=0.047) and blood sugar 2 hours after ingestion of 75 g glucose (p=0.045) at 24-28 weeks of gestation. Conclusion: Regard-
ing to the relationship between serum levels of 25(OH)D and blood sugar and insulin at the second trimester of pregnancy, it 
is recommended for pregnant women to take vitamin D supplementation.
Key words: gestational diabetes mellitus(GDM), 25-hydroxyvitamin D, vitamin D, pregnancy.
1. INTRODUCTION
Gestational diabetes mellitus (GDM) is considered as glucose 
intolerance with onset or first recognition during pregnancy (1). 
Prevalence of GDM during pregnancy ranges from 1 to 14 % of 
all pregnancies depending on the population under study and 
the diagnostic tests applied (2-4). The prevalence of this type of 
deficiency is 4.7 % among Iranian pregnant women (5). GDM 
is associated with increase in risks of maternal and neonatal 
gestational complicacy and delivery problems, including pre-
eclampsia, preterm labor, cesarean delivery, fetal macrosomia 
and neonatal hypoglycaemia (6, 7). Those issues trigger GDM 
become an essential topic for investigation (1) that increases 
concern in vitamin deficiency as a potential cause (8). Although 
epidemiologic studies have shown a relatively consistent connec-
tion between vitamin D deficiency and a higher risk of type 2 
diabetes mellitus (9, 10) and although obesity is associated main-
ly with both GDM (11,12)and vitamin D deficiency(13-15), 
it remains dubious whether vitamin D level risks a mother to 
experience GDM or not. Vitamin D is a prohormone that can 
be gained from both dietary factors and sunlight exposure (16). 
The prevalence of 25(OH)-vitamin D deficiency and insuf-
ficiency is increasing in Western societies and is particularly 
common in women of reproductive age and during and after 
pregnancy (17, 18). Vitamin D deficiency during pregnancy has 
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been connected to maternal osteomalacia, GDM, preeclampsia, 
small birth size, respiratory diseases, impaired fetal growth and 
bone development later in childhood (19-21), and more recently 
adequate vitamin D level has been linked to embryonic neuro-
development (22,23). Epidemiological data have shown that 
pregnant women with GDM were probably being vitamin D 
deficient (24). A few studies support relationship between low 
25-hydroxyvitamin D (25[OH]D) levels and an increased risk 
of GDM (25-28), but a recent prospective study did not find 
any evidence of an association between first-trimester 25(OH)
D levels and the further development of GDM (29). Due to 
previously found differences in vitamin D status in pregnant 
women, and because pregnancy is a vulnerable period for both 
the woman and the growing fetus, the aim of this study was to 
compare of serum levels of 25-hydroxyvitamin D in pregnant 
women at risk for GDM and women without risk factors.
2. PATIENTS AND METHODS
This cross-sectional study was carried out on 155 pregnant 
women, who do not yet finished the first trimester of pregnancy 
(less than 12 weeks gestation). They were selected among 400 
pregnant women with gestational age less than 12 weeks during 
the 5 month, who referred to Shahrekord prenatal care clinics 
affiliated to Shahrekord University of Medical Sciences,Iran. 
The design of study was approved by the Ethics Committee of 
Shahrekord University of Medical Science,Iran. Consent forms 
were filled in by participants of this study .All the participants 
have the inclusion criteria in this study. All of them were clini-
cally and thoroughly examined and their medical and health 
history were completely collected and recorded. The inclusion 
criteria in this study were: complete and full consent, no intake 
of calcium supplementation and vitamin D during the past 6 
month, the absence of any history of chronic liver disease, renal, 
endocrine, heart and respiratory disease based on examina-
tion and record history, no diagnosed diabetes type 1 and 2, 
no medication intake medication influence on metabolism, 
vitamin D homeostasis during the past 6 months and not hav-
ing previous history of GDM. Exclusion criteria included: lack 
of consent to continue the follow-up, lack of referring for the 
next follow-ups, lack of consent to OGTT in the first trimester, 
emergence of any chronic liver, renal, endocrine, cardiovascular 
and respiratory disease during pregnancy, emergence of any 
adverse obstetrical events during pregnancy, forced consump-
tion of drugs influencing metabolism and hemostasis calcium 
and vitamin D during pregnancy and, definitive diagnosis of 
diabetes at the beginning of the study based on the experiments 
done. Method of Sampling was simple sampling. Pregnant 
women were randomized to two groups of high and low risk 
for GDM. They were referred to the laboratory for testing in 
the first trimester of pregnancy. A mount of their serum levels 
of 25(OH)D, blood sugar level, blood insulin level, levels of 
HbA1C, GDM, Ca (calcium), FBS (FBS) and albumin were 
measured. Then, they were again examined between weeks of 
24 to 28 based on the standard method using 75 gr of glucose 
powder (30) and other OGTT were measured based on the ex-
amination which were done for them during the first trimester 
of pregnancy. In the case that any of the pregnant women suffer 
from severe Vitamin D deficiency, they were excluded from the 
study and were treated. Experiments were performed in a single 
laboratory using Electrochemiluminiscence method by means 
of Cobas E411 device manufactured by Roche-Hitachi-Cobas 
Company (2010).
2.1. Statistical analysis
All data were entered and analyzed by using SPSS software 
version 17. Statistical analysis of the data was performed using 
the T test, ANOVA and Pearson correlation coefficient.
3. RESULTS
In the first phase of this study, the data related to a total of 
155 pregnant women were collected and in the second phase, 
64 of these women attended for complementary examinations. 
They aged from 18 to 43 years with an average of 5.3 ± 27.4 
years. Their weight range from 42 to 111 kg with an average of 
11.7 ± 64.6 kg. BMI (body mass index) of these people ranges 
from 16.5 to 45 with an average of 4.8 ± 25.3 kg/m2. Systolic 
and diastolic blood pressure were in the range of 70 to 150 mm 
Hg, with an average of 12.1 ± 106 mm Hg and 50 to 80 with an 
average of 10.4 ± 62.6 mm Hg respectively. 116 (74.8%) of them 
live in urban areas and others reside in rural areas. 16 (10.3%) 
of them were employed and the rest were housewives. ANOVA 
showed no association between serum levels of 25(OH)D and 
the number of pregnancies (p =0.88). T-test showed no asso-
ciation between serum levels of 25(OH)D (p =0.21) with the 
place of residence. The t-test showed no significant association 
between serum levels of 25(OH)D and the number of preg-
nancy (p =0.49). As shown in Table 1., there were a significant 
relationship between serum levels of 25(OH)D in pregnant 
women in their first trimester of pregnancy and physiological 
characteristics including age (p=0.95), weight (p =0.19), BMI 
(p =0.09), systolic blood pressure (p =0.23) and diastolic blood 
pressure (p =0.63).
p valueCorrelation coefficientFactor
0.9490.005Age
0.1960.104-Weight
0.090.133-Body mass index(BMI) 
0.2350.960-Systolic blood pressure
0.6290.039-Diastolic blood pressure
Table 1. Association between serum vitamin D levels in 
pregnant women in the first trimester of pregnancy with their 
physiological characteristics
The results of metabolic parameters in the first and second 
trimester of pregnancy in patients are summarized in Table 2. 
Defining the risk factors for GDM (based on the Standard of 
Medical Care in Diabetes-2012, American Diabetes Associa-
tion (31), 27 of 155 patients (17.4 %) were diagnosed with high 
risk based on the existence of at least one of the following cri-
teria “BMI≥35, history of GDM, birth weight of more 4 kg, 
and positive family history for type 2 diabetes. Average level of 
serum of 25(OH)D for 64 of the cases who were referred in the 
second trimester(No.64)first trimester (No.155)variable
Min.Max.mean±SDMin.Max.mean±SD
6518421.2±88.8711638.10±7.89Fasting blood sugar
6816527.5±112.1501971.18±3.93
Random blood sugar 
(BS) (mg/dl)
8.210.20.4±9.27.5140.5±8.9Calcium(mg/dl)
33.90.1±3.527.10.4±4Albumin(gr)
9.3142.324.1±39.513.46159.225.9±45.6Vitamin D
4.17.90.8±5.847.20.7±5.8Hb A1C (%)
0.684.913.5±11.10.217514.3 ±6.3insulin
Table 2. Results of metabolic parameters in patients during the 
first and second trimester of pregnancy
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second trimester was 32.11 ± 53.9 (ng / ml) at the beginning of 
the study and was 24.1 ± 39.5 (ng / ml) in the second trimester. 
Paired t-test showed a significant decrease in the levels of serum 
of 25(OH)D in the second trimester compared to the first tri-
mester (p <0.001). There was no significant difference for levels 
of serum of 25(OH)D at the beginning and end of the study 
in the high risk group comparing the low-risk group (Table 3).
p valueHigh riskLow riskGroup
mean±SDmean±SD
Measurement stage
0.5821.1± 43.126.9± 46.2First trimester(n=155)
0.993.17±39.625.5±39.5Second trimester(n=64) 
Table 3. Levels of Vitamin D in pregnant women the first and 
second trimester in low-risk and high-risk groups
The relationship between serum levels of 25(OH)D and 
metabolic factors in the first and the second trimester based on 
the Pearson correlation coefficient is shown in Table 4. There 
was a direct and significant correlation between serum levels of 
25(OH)D in early pregnancy and fasting blood sugar. In other 
words, in the case of decrease in the level of serum of 25(OH)D 
in early pregnancy , fasting blood sugar may also be decreased 
and vice versa. It was also found that a serum levels of 25(OH)D 
in early pregnancy in the first trimester of pregnancy associated 
with HbA1C. There was a direct and significant correlation in 
the second trimester of pregnancy. Based our findings, there 
was a significant and inverse correlation between serum levels 
of 25(OH)D in early pregnancy and HbA1C level in the first 
trimester of pregnancy and there is a direct and significant cor-
relation between serum levels of 25(OH)D in early pregnancy 
and HbA1C level in the second trimester of pregnancy. It means 
that in the first trimester of pregnancy, serum levels of 25(OH)D 
reduced with the increase of HbA1C levels .While in the second 
trimester of pregnancy, the level of serum of 25(OH)D reduced 
with the decrease of HbA1C levels. There was a significant cor-
relation between serum levels of 25(OH)D and postprandial 
glucose levels in the second trimester of pregnancy. In fact, at 
the end of pregnancy, the amount of resistance to insulin reaches 
to the highest level and in the case, vitamin D have impact on 
the insulin secretion, probably with the decrease of vitamin D 
level, the level of insulin secretion will be reduced as well and 
this cause increase in the blood sugar. It was shown that there 
was significant and inverse correlation between serum levels of 
25(OH)D in the first and second trimester of pregnancy and 
serum insulin levels at the end of pregnancy. In other words, the 
reduction of serum levels of 25(OH)D both at the beginning 
and at the end of pregnancy increase blood insulin levels in the 
pregnant women at the end of pregnancy. While serum levels 
of 25(OH)D in early pregnancy did not change serum insulin 
levels significantly. In this study, there was not a significant as-
sociation between serum levels of 25(OH)D in the first trimester 
of pregnancy and incidence of GDM in the second trimester. 
Although there was a significant association between decrease of 
serum levels of 25(OH)D in the second trimester of pregnancy 
and increase in postprandial blood sugar / glucose, the increase 
is not enough to make the test of diagnosis of GDM positive. In 
this study, there was no significant relationship between serum 
levels of 25(OH)D in the first and second trimester of pregnancy 
and calcium and serum albumin level (Tables 5, 6).
(p value)Correlation coefficientFactor
0.1150.201-Fasting blood sugar (FBS)
0.047*0.252-OGTT
0.1320.192Calcium
0.4470.098Albumin
0.9680.005-Hb A1C
0.047*0.246-Insulin
Table 5. Relationship between vitamin D levels and metabolic 
factors in the second trimester of pregnancy *p<0.05
Type of test mean±SD p value
OGTT*(+) 7.7 ± 3.41
0.206
OGTT(-) 4.46±56
Table 6. Vitamin D levels in the first trimester of pregnancy 
based on the incidence of pregnancy diabetes in the second 
trimester * (Blood sugar two hours after 75 g glucose 
intake≥155)
4. DISCUSSION
Vitamin D deficiency during pregnancy is associated with 
adverse outcomes. This is essentially an issue of health world-
wide (32).The main sources of vitamin D in the body is diet and 
supplementations containing vitamin D and the production of 
this vitamin in the skin exposed to sunlight. Biologically active 
form of vitamin D is 1, 25- [OH] 2 D, while the 25- [OH] 2 D is 
a better indication of vitamin D status in the body as the main 
mechanism for the renal and non-renal production is 1,25- [OH] 
2 D and have a higher half-life and higher blood concentrations 
than 1,25- [OH] 2 D (27). It is expected that normal level of 
vitamin D in pregnant women be 18-27 ng in the first trimester 
and 10-22 ng / ml in the second trimester (30). Accordingly, 
in the present study, of 155 pregnant women in the first tri-
mester, 96.1 % have an optimal serum levels of 25(OH)D and 
3.9% below the optimal level (ng / ml <18), respectively. In the 
second trimester ,of 64 pregnant women 90.6% have Optimal 
levels of serum levels of 25(OH)D and 9.4% lower than optimal 
levels (ng / ml <10), respectively. As it is described in the result 
of this study, decrease of levels of serum levels of 25(OH)D in 
the second trimester has been very significant comparing to the 
first trimester of pregnancy. This represents a severe reduction 
of serum levels of 25(OH)D in the second trimester compared 
to the first trimester of pregnancy in our study population. It 
seems that significant reduction of serum levels of 25(OH)D is 
much higher that can be justified by dilution of blood during 
pregnancy and following that, decrease of vitamin D concen-
tration. In this study, no significant correlation was observed 
between serum levels of 25(OH)D and GDM among pregnant 
women at high and low risk. Unlike previous studies, this study 
Second trimester 
(no=64)
First trimester 
(no=155)
p valueCorrelation coefficientP value
Correlation 
coefficient
0.123-0.196*0.0030.238Fasting blood sugar(FBS)
0.249-0.1460.291-0.085Postprandial blood sugar(BS)
0.0770.2240.344-0.077calcium
0.3600.1170.6350.038albumin
*0.0470.249*0.007-0.217HbA1C
*0.012-0.3110.6710.034insulin
Table 4. Relationship between vitamin D and metabolic factors 
in the first trimester of pregnancy *p<0.05
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has been investigated pregnant women in different gestational 
age (first trimester and second trimester). Considering to this 
fact that the physiological condition of the pregnant person 
(such as blood volume in circulation, blood levels of HCG 
hormone, the expected levels of vitamin D, etc.) is different in 
each of this time period, result of this study is likely to be more 
precise than the similar studies in the past in the indication of 
the relationship between serum levels of 25(OH)D and blood 
sugar level of pregnant women. The climate, geography and 
culture of research community were in a way that reduces the 
amount of cooperation and participation of pregnant women. 
In this study, the relationship between serum levels of 25(OH)
D and GDM was examined with the aim of effectiveness of 
vitamin D level on the incidence of this disease. Contrary to 
what some previous literatures were said on the prevalence of 
vitamin D deficiency in women with GDM than in normal 
pregnant women (32-34, 28), this study did not confirm such an 
outcome. In fact, no significant difference is observed a in serum 
levels of 25(OH)D in the pregnant women at risk of incidence 
of GDM in both the first and the second trimester of pregnancy 
comparing to the pregnant women lack of risk factor. In previ-
ous studies, it was only examined the relationship between the 
vitamin D level and the incidence of GDM and type 2 diabetes 
and it was not clearly examined the relationship between the 
level of this vitamin and risk factors of incidence of gestational 
diabetes. It was found that those pregnant women, who in the 
second trimester of pregnancy have higher blood sugar level 
after taking 75 g glucose, have lower serum levels of 25(OH)D.
It should also be noted that recent studies provide no evi-
dence of association between serum 25OHD levels in the first 
trimester of pregnancy and gestational diabetes (35). In addi-
tion, in the second trimester of pregnancy, insulin levels were 
higher in women who had lower vitamin D levels. Rudnicki 
and Pedersen described previously considering to this fact that 
the prescription of vitamin D in pregnant women with gesta-
tional diabetes affect glucose and insulin levels and decreases 
blood sugar and blood insulin level expressed the mechanism 
of increase in sensitivity to insulin by vitamin D (33). Besides, 
the effect of vitamin D deficiency on the decrease of insulin 
secretion in mice and humans as well as the mechanisms of 
decrease function of cells of pancreatic beta and reduction in 
glucose tolerance had already been investigated (26). In this 
study, the incidence of GDM was measured through OGTT 
test by 75 g of glucose and measurement of blood sugar 2 hours 
after its intake and that was 14.1 %, which was higher than the 
prevalence reported in the medical texts (3% to 10%). In this 
study, there was a significant and inverse relationship between 
serum levels of 25(OH)D in early pregnancy (first trimester) 
and HbA1C levels at the same age of pregnancy (first trimester), 
whereas there is a significant and direct relationship between 
fasting plasma glucose (unlike some of the previous literature 
(36) ). In other words, those who have lower levels of vitamin D 
at the time of pregnancy had higher levels of HbA1C, but lower 
level of fasting blood glucose levels in the first trimester of preg-
nancy, and vice versa. This is perhaps because at the beginning 
of pregnancy, secretion of hormones such as GH, ACTH, and 
cortisol influence blood sugar and interfere in the assessment 
of the relationship between vitamin D and blood sugar levels. 
Previously, several studies have investigated the relationship 
between vitamin D and HbA1C (37, 28). For example in 2009, 
a case-control study has carried out by Alamolhoda and col-
leagues on 60 pregnant women in the case group and 61 women 
with no history of disease as the control group (38). However, it 
was found that there is a inverse relationship between vitamin 
D levels in the first trimester and HbA1C level in the second 
trimester of pregnancy. Since HbA1C blood sugar is the best 
predictive factor of blood sugar, probably the measured HbA1C 
in the first trimester of pregnancy has been associated with blood 
sugar level pre-pregnancy and as far as these women has been 
referred to many gynecologists for their prenatal care, probably 
vitamins supplementation intake before doing experiments 
associated with the second trimester of pregnancy. Although 
in this study no clearly significant association between serum 
levels of 25(OH)D and risk of GDM was found, according to 
what was explained in this study, we can probably confirm partly 
what come in earlier literature in connection with significant 
relationship between low serum levels of 25(OH)D and increase 
in blood sugar level and insulin resistance in pregnancy.
5. CONCLUSION
Evidence suggests a possible role of vitamin D deficiency in 
the pathogenesis of type 2 diabetes. Changes in serum levels 
of 25(OH)D or function of this vitamin in the body maybe 
influence insulin allergy (allergic reaction to insulin), pancre-
atic beta cell function or both of them. In addition, it has been 
found that several genes are associated with vitamin D in the 
pathogenesis of this disease. Therefore, vitamin D and its related 
immune and metabolic pathways may be involved to the patho-
genicity of type 2 diabetes through heredity and environment 
(39). The possible role of vitamin D in the type 2 diabetic is 
not completely clear. In addition, more information about this 
topic may identify new targets for treatment and prevention 
of this disease. Therefore requires further investigation about 
this case. Given that the percentage of incidence of pregnant 
women to vitamin D deficiency in this study was 14.1 % and it 
is higher than stated in previous studies, it seems that this is-
sue requires special attention to the health of pregnant women 
in ChaharMahal and Bakhtiari province considering to the 
prevention of this disease. Regarding to what is said about the 
relationship between vitamin D, blood sugar and blood insulin 
levels in the second trimester of pregnancy and also due to the 
influence of the human placental lactogen (hpl) in competition 
with insulin in the second trimester, it seems that intake of vi-
tamin D supplements can be very useful for pregnant women 
not to suffer from GDM.
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